FCMI
LOXO

Foresite Capital Management II’s Loxo Oncology, Inc LOXO Stock Holding History

Foresite Capital Management II’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11,900
Closed -$1M – 14
2017
Q4 		$1M Sell
11,900
-2,400
-17% -$200K 0.35% 10
2017
Q3 		$1.32M Buy
+14,300
New +$1.11M 0.53% 10

Other funds holding LOXO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Foresite Capital Management II's LOXO Position: Q1 2018 in Review

Foresite Capital Management II sold out of Loxo Oncology, Inc (LOXO) in Q1 2018, closing a stake of 11,900 shares — an estimated $1M sold.

Foresite Capital Management II first reported a position in LOXO in Q3 2017 and held it in 2 quarters. The position peaked at $1.32M in Q3 2017. 158 funds tracked by Wall St. Rank hold LOXO as of Q1 2018.

  • Foresite Capital Management II reported no remaining Loxo Oncology, Inc position as of Q1 2018 after selling out during the quarter.
  • Foresite Capital Management II sold 11,900 Loxo Oncology, Inc shares in Q1 2018, an estimated $1M.
  • Foresite Capital Management II first reported a position in Loxo Oncology, Inc in Q3 2017 and held it in 2 quarters.
  • Foresite Capital Management II's Loxo Oncology, Inc position peaked at $1.32M in Q3 2017.
  • 158 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2018.

Based on Foresite Capital Management II's 13F filing for Q1 2018, filed 15 May 2018.